Tdap / Td ACIP Vaccine Recommendations
Advisory Committee for Immunization Practices (ACIP)
On This Page
as Published in Morbidity and Mortality Weekly Report (MMWR)
The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).
CURRENT Tdap / Td Vaccine Recommendations
- MMWR, June 29, 2012, Vol 61, #25
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older — ACIP, 2012
Print version [20 pages] - MMWR, September 23, 2011, Vol 60, #37
FDA Approval of Expanded Age Indication for a Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine
Print version [1.59MB, 32 pages] - MMWR, January 14, 2011, Vol 60, #01
Updated Tdap Vaccine Recommendations from the ACIP, 2010
Print version [1.18MB, 36 pages] - MMWR, August 1, 2008, Vol 57, #RR-06
Recommendations for Postexposure Interventions to Prevent Infection with Hepatitis B Virus, Hepatitis C Virus, or Human Immunodeficiency Virus, and Tetanus in Persons Wounded During Bombings and Other Mass-Casualty Events — United States, 2008
Print version [28 pages]
Adolescents
- MMWR, March 24, 2006, Vol 55, #RR-03
Preventing Tetanus, Diphtheria, and Pertussis Among ADOLESCENTS: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines- Appendix A | Appx B | Appx C | Appx D | Appx E | Appx FNote: If you are using the HTML version of this document, be sure to access all links to get the complete content of the document, which includes 6 important appendices.
Print version [50 pages] (includes appendices) (summary)
- Appendix A | Appx B | Appx C | Appx D | Appx E | Appx FNote: If you are using the HTML version of this document, be sure to access all links to get the complete content of the document, which includes 6 important appendices.
Adults (under 65 years old)
- MMWR, December 15, 2006, Vol 55, #RR-17
Preventing Tetanus, Diphtheria, and Pertussis Among ADULTS: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines- Appendix A | Appendix B | Appendix CNote: If you are using the HTML version of this document, be sure to access all links to get the complete content of the document, which includes important appendices.
Adults 65 years and older
- MMWR, June 29, 2012, Vol 61, #25
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older, ACIP 2012
Print version [20 pages]
Tdap and Td Vaccines and Pregnancy
- MMWR, February 22, 2013, Vol 62, #7
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women – ACIP, 2012
Print version [1.11MB, 28 pages] - MMWR, October 21, 2011, Vol 60, #41
Updated Recommendations for Use of Tdap in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months – ACIP, 2011
Print version [32 pages]
ARCHIVED Historical Tdap / Td Immunization Publications
For your convenience, these archived publications can be used for historical and research purposes.
- MMWR, April 17, 2009, Vol 58, #14
FDA Approval of Expanded Age Indication for a Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine
Print version [2.07MB, 32 pages]
Tdap and Td Vaccines and Pregnancy Immunization
- MMWR, May 30, 2008, Vol 57, #4
Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and Their Infants- Appendix A | Appendix B
- Print version [56 pages] (includes appendices)
- Page last reviewed: November 21, 2014
- Page last updated: September 1, 2017
- Content source: